
President/Owner, Doctors of Pharmacy, Inc.
Member of the Healthcare Council
David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at Employee Health Insurance Management, a pharmacy benefit manager. He has over 30 years of experience, specializing in pharmacy services to long term care facilities such as nursing homes, and assisted living facilities, as well as the retail pharmacy industry. In addition, Dr. Zimmerman has served on the Speakers Bureau of several drug manufacturers on a variety of specialty and psychiatric drug products. He has also spoken at numerous professional associations and national meetings on topics from management and administration to clinical uses of drugs. Dr. Zimmerman has been and currently serves as an Adjunct Professor of clinical pharmacy at Ferris State University College of Pharmacy and The University of Michigan College of Pharmacy. Dr. Zimmerman is currently licensed as a pharmacist in Michigan and Arizona. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.
February 11, 2008
Teva wins FDA OK to sell generic Fosamax | www.reuters.com
It is important to understand the generic implications when it comes to drug product olacement on the formulary.
February 11, 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa | www.fiercebiotech.com
This article is informative because it draws conclusions about Zyprexa.
daily use Cialis---a good idea!
January 11, 2008
Cialis Is Cleared for Daily Use | online.wsj.com
Physicians have been prescribing lower dose Cialis...off label... for a long time. The FDA finally agreed and approved it.
October 19, 2007
Pfizer Abandons Exubera, Posts 77% Earnings Decline | online.wsj.com
Exubera is a great product. However, the delivery system was difficult to use and educate the patients how to use. Hopefully, the next generation of the product will be in a smaller more user friendly cannister.
| Study Group Name | No. Members |
|---|---|
| Experts in the Leisure & Lodging Council | 4887 |
| Experts in the Automotive Council | 3422 |
| Pharmacists (US) | 2077 |
| Generic Drug Economic Experts | 766 |
| Economic Experts on Managed Care | 714 |
David Zimmerman has not participated in any GLG Live Meetings.